gefitinib - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
IRESSA gefitinib 250 mg tablet blister pack AUST R: 90010Active ingredients:
gefitinib
Dosage form:
Tablet, film coated
Sponsor:
AstraZeneca Pty Ltd
Phone:
1800805342
|
Deletion from market:
01 Apr 2026
|
Shortage status:
To be discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative brand is available.
|